Weight loss is not what it used to be.The old mantra is “eat less, move more”, just does not reduce it for many people, especially those who deal with hormonal, genetic or metabolic blocks. Now in the fight of India has come a new powerful tool: Wegovy (Semaglutide 2.4mg), a heavily bewildered injection of weight loss that has already made waves in the US and Europe.But is it just another excitement diva, or is it a real medical breakthrough? We talked to some of India’s best endocrinologists, gynecologists and diabetes specialists – and their answers can surprise you.
What is Wegovy?
Wegovy-it’s trademark for a higher dose Semaglutide, Agonist of the GLP-1 receptor, originally designed to control type 2 diabetes. It imitates the hormone that regulates the level of hunger and insulin. Saying a simpler expression: it makes you feel full faster, eat less and burn fat more effectively – everything, improving blood sugar control.And no, it’s not a magical skinny shot. But it can be the closest modern science that offers, especially for obese people who have not seen results in the diet and exercise.
Epidemic of Obesity India: Why Vegavi arrival
According to experts, such as Dr. Mufazal has been lacquered, India is obese, and the second for type 2 diabetes and minimal access and surgical sciences, Sir HN Reliance Foundation, Hospital, Mumbai, Wegovy is more than just another drug.“There is no such thing as” healthy obesity “. Even if the complications are not yet visible, long-term risks-construction, cancer, diabetes are very real,” he says. “The first step is to consider obesity as a disease, not a cosmetic problem.”This change of attitude can finally push the Indian public – and politicians – to take weight seriously.
Over kilograms: Real Vegovi Preferences
One of the most impressive things about Vegov is that its impact goes far beyond the weighing.According to Dr. Ambris Mitala, the chairman and head of the Max Healthcare endocrinology, it is not just about giving up a few pounds.“Semaglutide 2.4 mg enhances saturation, as well as reduces heart events by 20% in overweight people or obese in the former heart disease,” he explains. “This is a big breakthrough.”Thus, while stories can focus on rapid weight loss, doctors are more excited about what is happening inside the body – an advanced insulin function, a decrease in inflammation and even potential neuroprotector, according to Dr. Ag Unnikrishnan, CEO of the Czellaram Institute.“It restores the integrity of the circulatory barrier and improves the interaction of astrocyt-vascular,” he says. “This can be a change in the game for overall metabolic health, not just weight.”
A lifelong circle for diabetics and postpartum women
Wegovy can also become the most important life circle for people with type 2 diabetes and women who are fighting with postpartum weight gain or PCO.Dr. Shashanka Joshka, a well -known endocrinologist at the Lilovati Hospital, explains: “Semaglutide is valuable for diabetes patients who are obese. What is most concerned about us is his ability to restore metabolic homeostasis at the cellular level.”Meanwhile, Dr. Rishma Pai, the chief gynecologist based on Mumbai, emphasizes how the drug can help break the obesity cycle between generations. “We see an increase in abdominal obesity trends in women of reproductive age. About 12-13% of pregnant and postpartum women in India are obese. Vegov in combination with lifestyle changes can significantly improve the results of the mother’s health.”
Not a label but a scientific strategy
The word “weight loss drugs” often becomes unclear – thanks to many cunning fat vodka, which in the past flooded Indian markets. But the doctors are clear: the vega is not a label. This is science.Dr. V. Mohan, a leading voice in diabetes, says: “It is not only about dropping pounds. He solves all the obesity-diabetes-metabolic triad syndrome, which is extremely common in Indian patients. We needed something similar to the year.”Experts also see the vegovy as a necessary alternative to Boriatric surgery, especially for patients who are not eligible and are not ready to go under the knife.“This can be an addition to those who resume weight after surgery or option for those who are not eligible for it,” the doctor added.
So who should take it?
Wegovy is not assigned to everyone. This is specifically designed for:Adults with BMI 30 or more (obesity)Adults with BMI with 27 or more, which also have weight -related problemsThis is not a drug drug. This therapy subject to the doctor should be part of a wider slimming plan, which includes a balanced diet and regular movement.
Risks and realities
Like any drug, Wegovy is not a side effect. Nausea, vomiting, constipation and headaches – some of the frequently reported questions, especially in the first weeks.And this is not a magic wand. Once you stop taking it, the weight can return if there is no long -term lifestyle change. That is why all doctors emphasize the importance of mating the drug with behavioral support and nutritional guidance.“Obesity, such as Wegovy, should be assessed not only by weight loss percentage, but also by their ability to change the rigid clinical results-BLD, SCD and potentially expanding their lives. Time we see these therapies as tools for longevity and disease prevention, not just for weighing, “said Dr. Radzhev Kovil, head of Diabetology, Zandra Healthcare and co-founder of the Rang de Neela initiative.India has long regarded obesity as a will of freedom, not a medical condition. Vegov’s arrival can finally change this.When used reasonably – and affordable – Wegovy may not be just a drug. This may be a long -term call for waking up in India to consider obesity as a serious condition it really is.Vegavi is finally in India. This is not a surprise, but clinically proven slimming injection that solves metabolic dysfunction, improves heart health and can help people with diabetes, PCOS and obesity live better, longer than life. But this is not a solo act – healthy life habits still run the show.
